vs
INSMED Inc（INSM）与STURM RUGER & CO INC（RGR）财务数据对比。点击上方公司名可切换其他公司
INSMED Inc的季度营收约是STURM RUGER & CO INC的1.7倍（$263.8M vs $151.1M），INSMED Inc同比增速更快（152.6% vs 3.6%），STURM RUGER & CO INC自由现金流更多（$12.3M vs $-264.2M），过去两年INSMED Inc的营收复合增速更高（86.9% vs 5.1%）
Insmed Inc.是一家全球性生物制药公司，专注于为存在高度未满足医疗需求的严重罕见病患者开发、商业化创新疗法，核心布局肺部、内分泌类罕见病治疗赛道，服务覆盖北美、欧洲及亚太地区的患者群体。
鲁格公司（Ruger）是总部位于美国康涅狄格州绍斯波特的枪械制造企业，除总部外，还在新罕布什尔州纽波特、北卡罗来纳州梅约丹以及亚利桑那州普雷斯科特设有生产工厂。公司由亚历山大·麦考密克·斯特姆与威廉·B·鲁格于1949年共同创立，自1969年起公开上市交易。
INSM vs RGR — 直观对比
营收规模更大
INSM
是对方的1.7倍
$151.1M
营收增速更快
INSM
高出149.0%
3.6%
自由现金流更多
RGR
多$276.5M
$-264.2M
两年增速更快
INSM
近两年复合增速
5.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $263.8M | $151.1M |
| 净利润 | $-328.5M | — |
| 毛利率 | 83.2% | 17.8% |
| 营业利润率 | -121.2% | 2.3% |
| 净利率 | -124.5% | — |
| 营收同比 | 152.6% | 3.6% |
| 净利润同比 | -39.5% | — |
| 每股收益（稀释后） | $-1.55 | $0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收INSMRGR
| Q4 25 | $263.8M | $151.1M | ||
| Q3 25 | $142.3M | $126.8M | ||
| Q2 25 | $107.4M | $132.5M | ||
| Q1 25 | $92.8M | $135.7M | ||
| Q4 24 | $104.4M | $145.8M | ||
| Q3 24 | $93.4M | $122.3M | ||
| Q2 24 | $90.3M | $130.8M | ||
| Q1 24 | $75.5M | $136.8M |
净利润INSMRGR
| Q4 25 | $-328.5M | — | ||
| Q3 25 | $-370.0M | $1.6M | ||
| Q2 25 | $-321.7M | $-17.2M | ||
| Q1 25 | $-256.6M | $7.8M | ||
| Q4 24 | $-235.5M | — | ||
| Q3 24 | $-220.5M | $4.7M | ||
| Q2 24 | $-300.6M | $8.3M | ||
| Q1 24 | $-157.1M | $7.1M |
毛利率INSMRGR
| Q4 25 | 83.2% | 17.8% | ||
| Q3 25 | 79.4% | 15.1% | ||
| Q2 25 | 73.9% | 3.9% | ||
| Q1 25 | 77.1% | 22.0% | ||
| Q4 24 | 75.0% | 22.8% | ||
| Q3 24 | 77.3% | 18.5% | ||
| Q2 24 | 76.8% | 22.3% | ||
| Q1 24 | 76.9% | 21.5% |
营业利润率INSMRGR
| Q4 25 | -121.2% | 2.3% | ||
| Q3 25 | -257.1% | -2.7% | ||
| Q2 25 | -291.3% | -15.6% | ||
| Q1 25 | -267.3% | 6.2% | ||
| Q4 24 | -220.6% | 7.8% | ||
| Q3 24 | -228.4% | 3.1% | ||
| Q2 24 | -319.8% | 6.9% | ||
| Q1 24 | -192.7% | 5.5% |
净利率INSMRGR
| Q4 25 | -124.5% | — | ||
| Q3 25 | -260.0% | 1.2% | ||
| Q2 25 | -299.5% | -13.0% | ||
| Q1 25 | -276.4% | 5.7% | ||
| Q4 24 | -225.5% | — | ||
| Q3 24 | -236.0% | 3.9% | ||
| Q2 24 | -332.8% | 6.3% | ||
| Q1 24 | -208.1% | 5.2% |
每股收益（稀释后）INSMRGR
| Q4 25 | $-1.55 | $0.22 | ||
| Q3 25 | $-1.75 | $0.10 | ||
| Q2 25 | $-1.70 | $-1.05 | ||
| Q1 25 | $-1.42 | $0.46 | ||
| Q4 24 | $-1.30 | $0.62 | ||
| Q3 24 | $-1.27 | $0.28 | ||
| Q2 24 | $-1.94 | $0.47 | ||
| Q1 24 | $-1.06 | $0.40 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.4B | $92.5M |
| 总债务越低越好 | $546.8M | — |
| 股东权益账面价值 | $739.0M | $283.8M |
| 总资产 | $2.3B | $342.0M |
| 负债/权益比越低杠杆越低 | 0.74× | — |
8季度趋势，按日历期对齐
现金及短期投资INSMRGR
| Q4 25 | $1.4B | $92.5M | ||
| Q3 25 | $1.7B | $80.8M | ||
| Q2 25 | $1.9B | $101.4M | ||
| Q1 25 | $1.2B | $108.3M | ||
| Q4 24 | $1.4B | $105.5M | ||
| Q3 24 | $1.5B | $96.0M | ||
| Q2 24 | $1.2B | $105.6M | ||
| Q1 24 | $595.7M | $115.3M |
总债务INSMRGR
| Q4 25 | $546.8M | — | ||
| Q3 25 | $546.8M | — | ||
| Q2 25 | $546.8M | — | ||
| Q1 25 | $1.1B | — | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $971.8M | — | ||
| Q2 24 | $1.2B | — | ||
| Q1 24 | $1.2B | — |
股东权益INSMRGR
| Q4 25 | $739.0M | $283.8M | ||
| Q3 25 | $945.6M | $279.6M | ||
| Q2 25 | $1.2B | $289.3M | ||
| Q1 25 | $99.2M | $321.5M | ||
| Q4 24 | $285.4M | $319.6M | ||
| Q3 24 | $483.4M | $314.9M | ||
| Q2 24 | $38.8M | $321.5M | ||
| Q1 24 | $-464.8M | $332.0M |
总资产INSMRGR
| Q4 25 | $2.3B | $342.0M | ||
| Q3 25 | $2.4B | $342.3M | ||
| Q2 25 | $2.5B | $349.5M | ||
| Q1 25 | $1.8B | $379.0M | ||
| Q4 24 | $2.0B | $384.0M | ||
| Q3 24 | $2.1B | $373.5M | ||
| Q2 24 | $1.8B | $376.7M | ||
| Q1 24 | $1.2B | $385.0M |
负债/权益比INSMRGR
| Q4 25 | 0.74× | — | ||
| Q3 25 | 0.58× | — | ||
| Q2 25 | 0.44× | — | ||
| Q1 25 | 11.31× | — | ||
| Q4 24 | 3.93× | — | ||
| Q3 24 | 2.01× | — | ||
| Q2 24 | 30.66× | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-247.6M | $15.5M |
| 自由现金流经营现金流 - 资本支出 | $-264.2M | $12.3M |
| 自由现金流率自由现金流/营收 | -100.1% | 8.2% |
| 资本支出强度资本支出/营收 | 6.3% | 2.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-967.6M | $38.5M |
8季度趋势，按日历期对齐
经营现金流INSMRGR
| Q4 25 | $-247.6M | $15.5M | ||
| Q3 25 | $-219.8M | $12.9M | ||
| Q2 25 | $-205.6M | $14.7M | ||
| Q1 25 | $-262.1M | $11.1M | ||
| Q4 24 | $-196.0M | $20.0M | ||
| Q3 24 | $-180.9M | $9.4M | ||
| Q2 24 | $-123.0M | $18.7M | ||
| Q1 24 | $-184.0M | $7.3M |
自由现金流INSMRGR
| Q4 25 | $-264.2M | $12.3M | ||
| Q3 25 | $-222.2M | $7.0M | ||
| Q2 25 | $-209.1M | $9.1M | ||
| Q1 25 | $-272.2M | $10.0M | ||
| Q4 24 | $-202.8M | $16.4M | ||
| Q3 24 | $-184.6M | $2.6M | ||
| Q2 24 | $-129.7M | $10.1M | ||
| Q1 24 | $-188.7M | $5.6M |
自由现金流率INSMRGR
| Q4 25 | -100.1% | 8.2% | ||
| Q3 25 | -156.1% | 5.5% | ||
| Q2 25 | -194.6% | 6.9% | ||
| Q1 25 | -293.2% | 7.4% | ||
| Q4 24 | -194.1% | 11.2% | ||
| Q3 24 | -197.6% | 2.1% | ||
| Q2 24 | -143.6% | 7.7% | ||
| Q1 24 | -250.0% | 4.1% |
资本支出强度INSMRGR
| Q4 25 | 6.3% | 2.1% | ||
| Q3 25 | 1.7% | 4.6% | ||
| Q2 25 | 3.2% | 4.2% | ||
| Q1 25 | 10.8% | 0.8% | ||
| Q4 24 | 6.5% | 2.5% | ||
| Q3 24 | 3.9% | 5.5% | ||
| Q2 24 | 7.5% | 6.6% | ||
| Q1 24 | 6.2% | 1.3% |
现金转化率INSMRGR
| Q4 25 | — | — | ||
| Q3 25 | — | 8.15× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.43× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.98× | ||
| Q2 24 | — | 2.27× | ||
| Q1 24 | — | 1.04× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
INSM
暂无分部数据
RGR
| Firearms | $150.6M | 100% |
| Castings | $7.3M | 5% |
